Human anti-CAIX mAbs that inhibit carbonic anhydrase (CA) enzymatic activity could kill RCC through NK cell-mediated ADCC, and the killing activity was positively correlated with the level of CAIX expression in RCC (Chang et al., 2015). Here, CA9 is linked to renal cell carcinoma.